Jag Capital Management LLC purchased a new stake in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Rating) in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 6,863 shares of the biopharmaceutical company’s stock, valued at approximately $4,952,000. Several other hedge funds and other institutional investors have […]
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Rating) had its price objective decreased by SVB Securities from $976.00 to $895.00 in a research report issued to clients and investors on Friday, The Fly reports. SVB Securities’ price target points to a potential upside of 17.44% from the stock’s previous close. A number of other brokerages have also […]
Donoghue Forlines LLC reduced its stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Rating) by 29.3% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 501 shares of the biopharmaceutical company’s stock after selling 208 shares during […]
Glenview Trust Co raised its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Rating) by 7.1% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 3,089 shares of the biopharmaceutical company’s stock after acquiring an additional 205 shares during the period. […]
Nwam LLC raised its position in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Get Rating) by 6.6% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,737 shares of the biopharmaceutical company’s stock after buying an additional 107 shares during the quarter. Nwam LLC’s holdings […]